Pulmatrix Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
/ 
Frequently asked questions
To buy Pulmatrix Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pulmatrix Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pulmatrix Inc. is PULM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pulmatrix Inc. has its primary listing on NASDAQ (Small cap). You can trade Pulmatrix Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pulmatrix Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Pulmatrix Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Pulmatrix Inc..